Wide Ranks

ATXI

Avenue Therapeutics, Inc.

2.06

Top Statistics
Market Cap 3 M Forward PE -0.6561 Revenue Growth 0.00 %
Current Ratio 4.30 Trailing PE 0.0831 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 4 M Total Cash Per Share 3.44 Total Debt
Total Debt To Equity Current Ratio 4.30 Book Value Per Share 4.63
All Measures
Short Ratio 73.00 % Message Board Id finmb_310815442 Shares Short Prior Month 31536
City Bay Harbor Islands Uuid ab3c15b5-e280-3b5c-b842-8e87c6276492 Previous Close 2.04
First Trade Date Epoch Utc 1 B Book Value 4.63 Beta -0.1790
Volume 21459 Price To Book 0.4444 Last Split Date 1 B
Fifty Two Week Low 1.60 Total Cash Per Share 3.44 Shares Short Previous Month Date 1 B
Target Median Price 8.00 Max Age 86400 Recommendation Mean 2.00
Sand P52 Week Change 0.3133 Target Mean Price 8.00 Net Income To Common -14676000
Short Percent Of Float 0.0356 Implied Shares Outstanding 1 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 27390 Average Volume10days 27390
Total Cash 4 M Next Fiscal Year End 1 B Held Percent Insiders 0.0985
Trailing PE 0.0831 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 2.04 Target Low Price 8.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 2.17 Open 2.00 Free Cashflow -13072750
State FL Dividend Yield 0.00 % Return On Assets -2.01
Time Zone Short Name EST Trailing Eps 24.78 Day Low 2.00
Address1 1111 Kane Concourse Shares Outstanding 1 M Price Hint 4
Target High Price 8.00 Website https://www.avenuetx.com 52 Week Change -0.8704
Average Volume 44578 Forward Eps -3.14 Recommendation Key buy
Compensation As Of Epoch Date 1 B Quick Ratio 423.70 % Last Split Factor 1:75
Regular Market Day High 2.09 Is_sp_500 False Profit Margins 0.00 %
Fifty Two Week High 26.48 Day High 2.09 Shares Short 50925
Regular Market Open 2.00 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0356 Operating Cashflow -8586000
Currency USD Time Zone Full Name America/New_York Market Cap 3 M
Is_nasdaq_100 False Zip 33154 Quote Type EQUITY
Industry Biotechnology Long Name Avenue Therapeutics, Inc. Regular Market Day Low 2.00
Held Percent Institutions 0.1033 Current Price 2.06 Address2 Suite 301
Financial Currency USD Current Ratio 4.30 Industry Disp Biotechnology
Number Of Analyst Opinions 1 Country United States Float Shares 1 M
Two Hundred Day Average 5.01 Enterprise Value -3093483 Forward PE -0.6561
Regular Market Volume 21459 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases.

Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders.

The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida.

Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.